August 3, 2017 10:41 AM EDT
News Briefing

Te­va talks tough on cuts; Take­da bol­sters start­up with a ded­i­cat­ed car­dio dis­cov­ery team

Shehla Shakoor

Managing Director

→ With its share price plum­met­ing as the rev­enue num­bers de­te­ri­o­rate at a rapid pace, Is­rael’s trou­bled Te­va talked up deep cuts to­day, with plans …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

FDA ap­proves Lil­ly's Zep­bound for sleep ap­nea, like­ly crack­ing open Medicare mar­ket

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

Sofinno­va out­lines $550M fund af­ter IPOs and M&A deals

A service from the Financial Times